Y Fukumoto Selected Research

Y Fukumoto Research Topics

Disease

2	Rupture 12/2005 - 01/2001
2	Pain (Aches) 06/2005 - 03/2001
2	Neoplasms (Cancer) 12/2001 - 01/2001
2	Atherosclerotic Plaque (Atheroma) 02/2001 - 01/2001
2	Thrombosis (Thrombus) 01/2001 - 08/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Sarcopenia 01/2017
1	Muscular Atrophy (Muscle Atrophy) 12/2014
1	Anaphylaxis (Anaphylactic Shock) 01/2007
1	Popliteal Artery Aneurysm 12/2005
1	Aneurysm (Aneurysms) 12/2005
1	Cyanosis 06/2005
1	Pathologic Constriction (Stenosis) 06/2005
1	Pulmonary Hypertension 03/2005
1	Colitis 05/2002
1	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2001
1	Reperfusion Injury 08/2001
1	Stroke (Strokes) 08/2001
1	Acute Liver Failure (Fulminant Hepatic Failure) 05/2001
1	Erythema 03/2001
1	Exanthema (Rash) 03/2001
1	Disseminated Intravascular Coagulation 12/2000
1	Renal Insufficiency (Renal Failure) 12/2000
1	Acidosis 12/2000
1	Mixed Connective Tissue Disease (MCTD) 12/2000
1	Multiple Organ Failure (MODS) 12/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2000
1	Muscle Spasticity (Spastic) 05/2000
1	Spasm (Spasms) 05/2000
1	Coronary Vasospasm (Coronary Artery Vasospasm) 05/2000
1	Type 2 Diabetes Mellitus (MODY) 03/2000
1	Diabetic Neuropathies (Diabetic Neuropathy) 03/2000
1	Meningitis 01/2000

Drug/Important Bio-Agent (IBA)

2	Matrix Metalloproteinases (MMPs)IBA 02/2001 - 01/2001
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2001 - 01/2001
1	Immunoglobulin G (IgG)IBA 01/2007
1	Immunoglobulin E (IgE)IBA 01/2007
1	Aprotinin (Trasylol)FDA Link 01/2007
1	Inosine Triphosphate (ITP)IBA 12/2005
1	Vasodilator Agents (Vasodilators)IBA 03/2005
1	fasudil (AT 877)IBA 03/2005
1	rho-Associated KinasesIBA 03/2005
1	Sulfonic AcidsIBA 05/2002
1	Ethanol (Ethyl Alcohol)IBA 05/2002
1	Oxygen (Dioxygen)IBA 12/2001
1	EnzymesIBA 11/2001
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2001
1	sivelestatIBA 08/2001
1	Adenosine Triphosphate (ATP)IBA 08/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2001
1	Interleukin-6 (Interleukin 6)IBA 08/2001
1	CytokinesIBA 08/2001
1	Interleukin-8 (Interleukin 8)IBA 08/2001
1	Leukocyte Elastase (Neutrophil Elastase)IBA 08/2001
1	MB Form Creatine KinaseIBA 08/2001
1	Secretory Proteinase Inhibitory ProteinsIBA 08/2001
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2001
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2001
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2001
1	CollagenIBA 02/2001
1	LipidsIBA 01/2001
1	cerivastatin (Kazak)FDA Link 01/2001
1	Thromboplastin (Tissue Factor)IBA 01/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2001
1	Dacarbazine (DIC)FDA LinkGeneric 12/2000
1	Proteins (Proteins, Gene)FDA Link 08/2000
1	Protein CIBA 08/2000
1	Heparin (Liquaemin)FDA LinkGeneric 08/2000
1	1,4-dihydropyridine (dihydropyridine)IBA 05/2000
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 05/2000
1	Nifedipine (Adalat)FDA LinkGeneric 05/2000
1	Serotonin (5 Hydroxytryptamine)IBA 05/2000
1	Methyl ester 1,4- dihydro- 2,6- dimethyl- 5- nitro- 4- (2- (trifluoromethyl)phenyl)- 3-Pyridinecarboxylic acidIBA 05/2000
1	Indicators and Reagents (Reagents)IBA 03/2000
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2000
1	Biomarkers (Surrogate Marker)IBA 01/2000
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2000

Therapy/Procedure

2	Therapeutics 12/2001 - 05/2001
1	Cardiac Rehabilitation 01/2017
1	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2014
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2007
1	Stents 06/2005
1	Enema (Enemas) 05/2002
1	Heart Transplantation (Grafting, Heart) 08/2001
1	Liver Transplantation 05/2001
1	Drug Therapy (Chemotherapy) 03/2001
1	Plasma Exchange 12/2000
1	Plasmapheresis 12/2000
1	Ligation 08/2000
1	Glycemic Control 03/2000